Literature DB >> 33837453

Frontiers of therapy for hepatocellular carcinoma.

Michael Heller1, Neehar D Parikh2, Nicholas Fidelman3, Dawn Owen4.   

Abstract

The incidence of hepatocellular carcinoma continues to increase worldwide. Fortunately, there have been notable recent advances in locoregional and systemic therapy. In this current review, we will highlight these new developments and future directions of hepatocellular carcinoma treatment and address the importance of a multidisciplinary approach to treatment.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Hepatocellular Carcinoma; Oncology; Radiation therapy; Systemic therapy; Transarterial radioembolization

Mesh：

Year:  2021        PMID： 33837453     DOI： 10.1007/s00261-021-03065-0

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  63 in total

Review 1.  Radioembolization with 90Y microspheres: angiographic and technical considerations.

Authors:  Robert J Lewandowski; Kent T Sato; Bassel Atassi; Robert K Ryu; Albert A Nemcek; Laura Kulik; Jean-Francois Geschwind; Ravi Murthy; William Rilling; David Liu; Lourens Bester; Jose Ignacio Bilbao; Andrew S Kennedy; Reed A Omary; Riad Salem
Journal:  Cardiovasc Intervent Radiol       Date:  2007-05-22       Impact factor: 2.740

2.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jorge A Marrero; Laura M Kulik; Claude B Sirlin; Andrew X Zhu; Richard S Finn; Michael M Abecassis; Lewis R Roberts; Julie K Heimbach
Journal:  Hepatology       Date:  2018-08       Impact factor: 17.425

3.  Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization.

Authors:  Ahsun Riaz; Vanessa L Gates; Bassel Atassi; Robert J Lewandowski; Mary F Mulcahy; Robert K Ryu; Kent T Sato; Talia Baker; Laura Kulik; Ramona Gupta; Michael Abecassis; Al B Benson; Reed Omary; Laura Millender; Andrew Kennedy; Riad Salem
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-24       Impact factor: 7.038

4.  Streamlining radioembolization in UNOS T1/T2 hepatocellular carcinoma by eliminating lung shunt estimation.

Authors:  Ahmed Gabr; Srirajkumar Ranganathan; Samdeep K Mouli; Ahsun Riaz; Vanessa L Gates; Laura Kulik; Daniel Ganger; Haripriya Maddur; Christopher Moore; Elias Hohlastos; Nitin Katariya; Juan Carlos Caicedo; Aparna Kalyan; Robert J Lewandowski; Riad Salem
Journal:  J Hepatol       Date:  2020-03-05       Impact factor: 25.083

5.  Trends in incidence, diagnosis, treatment and survival of hepatocellular carcinoma in a low-incidence country: Data from the Netherlands in the period 2009-2016.

Authors:  Margot T M Reinders; Suzanne van Meer; Mark C Burgmans; Koert P de Jong; Heinz-Josef Klümpen; Robert A de Man; D Sandjai Ramsoekh; Dave Sprengers; Eric T T L Tjwa; Judith de Vos-Geelen; Karel J van Erpecum; Lydia G M van der Geest
Journal:  Eur J Cancer       Date:  2020-08-13       Impact factor: 9.162

6.  Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy.

Authors:  Michael Vouche; Ali Habib; Thomas J Ward; Edward Kim; Laura Kulik; Daniel Ganger; Mary Mulcahy; Talia Baker; Michael Abecassis; Kent T Sato; Juan-Carlos Caicedo; Jonathan Fryer; Ryan Hickey; Elias Hohlastos; Robert J Lewandowski; Riad Salem
Journal:  Hepatology       Date:  2014-05-27       Impact factor: 17.425

7.  Same-day 90Y radioembolization: implementing a new treatment paradigm.

Authors:  Ahmed Gabr; Joseph Ralph Kallini; Vanessa L Gates; Ryan Hickey; Laura Kulik; Kush Desai; Bartley Thornburg; Karen Marshall; Krystina Salzig; Melissa Williams; Carlene Del Castillo; Daniel Ganger; Elias Hohlastos; Talia Baker; Robert J Lewandowski; Riad Salem
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-17       Impact factor: 9.236

Review 8.  Prevention and treatment of complications of selective internal radiation therapy: Expert guidance and systematic review.

Authors:  Bruno Sangro; Diego Martínez-Urbistondo; Lourens Bester; Jose I Bilbao; Douglas M Coldwell; Patrick Flamen; Andrew Kennedy; Jens Ricke; Ricky A Sharma
Journal:  Hepatology       Date:  2017-07-27       Impact factor: 17.425

9.  International trends in hepatocellular carcinoma incidence, 1978-2012.

Authors:  Jessica L Petrick; Andrea A Florio; Ariana Znaor; David Ruggieri; Mathieu Laversanne; Christian S Alvarez; Jacques Ferlay; Patricia C Valery; Freddie Bray; Katherine A McGlynn
Journal:  Int J Cancer       Date:  2019-11-05       Impact factor: 7.316

10.  Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C in China and the United States.

Authors:  Ming Yang; Neehar D Parikh; Huixin Liu; Elizabeth Wu; Huiying Rao; Bo Feng; Andy Lin; Lai Wei; Anna S Lok
Journal:  Sci Rep       Date:  2020-12-01       Impact factor: 4.379
View more
  3 in total

Review 1.  Clinical Implication of Circulating Tumor Cells Expressing Epithelial Mesenchymal Transition (EMT) and Cancer Stem Cell (CSC) Markers and Their Perspective in HCC: A Systematic Review.

Authors:  Santhasiri Orrapin; Sasimol Udomruk; Worakitti Lapisatepun; Sutpirat Moonmuang; Areerak Phanphaisarn; Phichayut Phinyo; Dumnoensun Pruksakorn; Parunya Chaiyawat
Journal:  Cancers (Basel)       Date:  2022-07-11       Impact factor: 6.575

2.  Identifying Potential Tumor Antigens and Antigens-Related Subtypes in Hepatocellular Carcinoma for mRNA Vaccine Development.

Authors:  Weiran Liao; Zhitian Shi; Haoren Tang; Tiangen Wu; Cheng Zhang; Yutao He; Renchao Zou; Lin Wang
Journal:  J Oncol       Date:  2022-08-29       Impact factor: 4.501

3.  Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma.

Authors:  Xi Chen; Gang Hu; Li Xiong; Qingqing Xu
Journal:  Pathol Oncol Res       Date:  2022-09-21       Impact factor: 2.874
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.